{"status": "OK", "response": {"docs": [{"type_of_material": "Biography; Series", "blog": [], "news_desk": "National Desk", "lead_paragraph": "In a concession to the biotechnology industry and its supporters on Capitol Hill, the chairman of a major Congressional committee decided today to drop President Clinton's proposal for a Federal agency to review the \"reasonableness\" of new drug prices. The chairman of the Energy and Commerce Committee, Representative John D. Dingell, said the proposal \"should not be included as part of any comprehensive health care reform,\" and he vowed to oppose it throughout the legislative process.", "headline": {"main": "New in Congress, but a Powerful Friend of Drug Companies"}, "abstract": null, "print_page": "24", "word_count": 882, "_id": "4fd1c58a8eb7c8105d6f5991", "snippet": "In a concession to the biotechnology industry and its supporters on Capitol Hill, the chairman of a major Congressional committee decided today to drop President Clinton's proposal for a Federal agency to review the \"reasonableness\" of new drug...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1994/04/21/us/new-in-congress-but-a-powerful-friend-of-drug-companies.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "SCHENK, LYNN"}, {"name": "persons", "value": "DINGELL, JOHN D"}, {"name": "organizations", "value": "CONGRESS"}, {"name": "subject", "value": "SURVEYS AND SERIES"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "PRICES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "1994-04-21T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Statistics", "blog": [], "news_desk": "Financial Desk", "lead_paragraph": "Merck & Company, the world's largest drug maker, reported yesterday that earnings rose 10 percent on strong sales in the first quarter, the first full quarter since Merck acquired Medco Containment Services, the big managed-care drug distributor. Merck said that after adjusting for the Medco acquisition, sales on a comparable basis rose 19 percent.", "headline": {"main": "Merck Posts Solid Results For Quarter", "kicker": "COMPANY REPORTS"}, "abstract": null, "print_page": "5", "word_count": 563, "_id": "4fd1b5ec8eb7c8105d6dbee8", "snippet": "Merck & Company, the world's largest drug maker, reported yesterday that earnings rose 10 percent on strong sales in the first quarter, the first full quarter since Merck acquired Medco Containment Services, the big managed-care drug distributor.   ...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1994/04/20/business/company-reports-merck-posts-solid-results-for-quarter.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "AMERICAN HOME PRODUCTS CORP"}, {"name": "organizations", "value": "MERCK & CO INC"}, {"name": "organizations", "value": "WARNER-LAMBERT CO"}, {"name": "subject", "value": "COMPANY REPORTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "1994-04-20T00:00:00Z", "section_name": "Business"}], "meta": {"hits": 2, "offset": 0, "time": 114}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}